Stage III Non-Small Cell Lung Cancer AJCC v7 Recruiting Phase 2 Trials for Paclitaxel (DB01229)

Also known as: Stage III Lung Non-Small Cell Cancer AJCC v7

IndicationStatusPhase
DBCOND0090379 (Stage III Non-Small Cell Lung Cancer AJCC v7)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04892953Local Consolidative Therapy and Durvalumab for Oligoprogressive and Polyprogressive Stage III NSCLC After Chemoradiation and Anti-PD-L1 TherapyTreatment